Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 6/20 | 1.00 |
| ▸ | ADH1B | P00325 | 4/20 | 1.00 |
| ▸ | ADH1A | P07327 | 4/20 | 1.00 |
| ▸ | ADH7 | P40394 | 4/20 | 1.00 |
| ▸ | ADH1C | P00326 | 3/20 | 1.00 |
| ▸ | ADH4 | P08319 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | FAAH | O00519 | 2/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.45 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL145544 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL9660807 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL9661679 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL302735 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL9661848 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL58363 | 1.00 | — | — | |
| SCHEMBL9658779 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL4879688 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL305123 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C | |
| SCHEMBL149028 | 1.00 | EPHX1 (1.00) | EPHX1ADH1BADH1AADH7ADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 381 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115572559-B | Anti-freezing optical cement and preparation method thereof | 中国科学院福建物质结构研究所 | 2023-11-17 | — | — | CN | claimed |
| CN-109641828-B | Method for separating formic acid from reaction mixture by extraction | OXFA有限公司 | 2022-03-29 | — | — | CN | claimed |
| CN-109641827-B | Method for the catalytic production of formic acid at low overpressure and for the regeneration of the catalyst used in the process | OXFA有限公司 | 2022-03-29 | — | — | CN | claimed |
| EP-3484847-B1 | METHOD FOR SEPARATING FORMIC ACID FROM A REACTION MIXTURE BY MEANS OF EXTRACTION | OXFA GMBH (DE) | 2020-10-28 | — | — | EP | claimed |
| CN-109128139-B | Synthesis process of Pt-Co cubic nanocrystalline | 温州大学 | 2020-09-29 | — | — | CN | claimed |
| EP-3484846-B1 | METHOD FOR CATALYTICALLY PRODUCING FORMIC ACID AND REGENERATING THE CATALYST USED IN THE PROCESS WITH LITTLE OVERPRESSURE | OXFA GMBH (DE) | 2020-09-23 | — | — | EP | claimed |
| CN-107866579-B | Synthetic method of multi-branch Pt metal nanocrystalline | 温州大学 | 2020-04-10 | — | — | CN | claimed |
| EP-3484847-A1 | METHOD FOR SEPARATING FORMIC ACID FROM A REACTION MIXTURE BY MEANS OF EXTRACTION | OxFA GmbH (DE) | 2019-05-22 | — | — | EP | claimed |
| CN-109641827-A | The method of catalytic production formic acid and catalyst used in the process of regenerating this under low over-voltage | OXFA有限公司 | 2019-04-16 | — | — | CN | claimed |
| CN-109641828-A | Method for separating formic acid from reaction mixture by extraction | OXFA有限公司 | 2019-04-16 | — | — | CN | claimed |
| EP-1189891-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION Bioscience AG (DE) | 2002-03-27 | — | — | EP | claimed |
| US-6362342-B1 | BIOSYNTHESIS; DRUG LIBRARIES | LION BIOSCIENCE AG (DE) | 2002-03-26 | — | — | US | claimed |
| WO-2001000594-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2001-01-04 | — | — | WO | claimed |
| US-5071994-A | Intermediates for positive working photographic compounds, analgesics; anti-inflammatory agents | FUJI PHOTO FILM CO., LTD. (JP) | 1991-12-10 | — | — | US | claimed |
| EP-0161626-B1 | SILVER HALIDE COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 1990-12-05 | — | — | EP | claimed |
| US-4950764-A | HERBICIDES, BACTERICIDES, ANALGESICS, ANTIINFLAMMATORY AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1990-08-21 | — | — | US | claimed |
| US-4690889-A | SUBSTITUTED NAPHTHOL, HEAT AND LIGHT FASTNESS | FUJI PHOTO FILM CO., LTD. (JP) | 1987-09-01 | — | — | US | claimed |
| US-20260078099-A1 | COMPOUND, PREPARATION METHOD THEREOF, AND LIPID NANOPARTICLE AND PHARMACEUTICAL COMPOSITION | SUZHOU HEALIRNA BIOTECHNOLOGY CO., LTD. (CN) | 2026-03-19 | — | — | US | disclosed |
| US-4171223-A | DEVELOPMENT INHIBITOR COMPRISING A 1,2,5-THIADIAZOLINE-1,1-DIOXIDE COMPOUND | AGFA-GEVAERT, A.G. (DE) | 1979-10-16 | — | — | US | disclosed |
| US-4072525-A | COLOR PHOTOGRAPHY | FUJI PHOTO FILM CO., LTD. (JA) | 1978-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078099-A1 | COMPOUND, PREPARATION METHOD THEREOF, AND LIPID NANOPARTICLE AND PHARMACEUTICAL COMPOSITION | SGMS1, LDLR, NR5A1 | EPHX1 628/4885ADH1B 1876/4885ADH1A 483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.